维普中文期刊产品整合服务
13篇 您的检索式:作者名="Magoc"
    题名 作者 年代 出处 被引量
1Preclinical activity of ABT- 869, a muhitargeted receptor tyrosine kinase inhibitor 显示文摘Albert DH Tapang P Magoc TJ 2006Mol Cancer Ther2006,5,4:1
2Preclinical activity of ABT-869, a multitargeted receptor tyroslne kinase inhibitor显示文摘ALBERT D H TAPANG P MAGOC T J 2006Mol Cancer Ther2006,5,4:1
3Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases显示文摘Michael L. Curtin H. Robin Heyman Robin R. Frey Patrick A. Marcotte Keith B. Glaser James R. Jankowski Terrance J. Magoc Daniel H. Albert Amanda M. Olson David R. Reuter Jennifer J. Bouska Debra A. Montgomery Joann P. Palma Cherrie K. Donawho Kent D. Stew 2012Bioorganic & Medicinal Chemistry Letters2012,,14:1
4Preclinicai activity of ABT-869,a muhitargeted receptor tyrosine kinase inhibitor 显示文摘ALBERT DH TAPANG P MAGOC TJ 2006Mol Cancer Ther2006,5,4:1
5Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor显示文摘ALBERT DH TAPANG P MAGOC TJ 2006Mol Cancer Ther2006,5,4:1
6FLASH:fast length adjustment of short reads to improve genome assemblies 显示文摘Magoc Salzberg S L 2011Bioinformatics2011,27,21:1
7Cyp12a4 confers lnfenuron resistance in a natural population of Drosophila melanogaster 显示文摘Bogwitz M R Chung H Magoc L 2005Proceedings of the National Academy of Sciences of the United States of America2005,102,12:1
8Cross-resistance to dicyclanil in cyromazine resistant mutants of Drosophila melanogaster and Lucilia cuprina 显示文摘Magoc L Yen J L Hill-Williams A 2005Pestic Biochem Physiol2005,81,2:1
9Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist 显示文摘ALBERT D H CONWAY R G MAGOC T J 1996J Pharmacol Exp Ther1996,277,3:1
10Pathogen-derived Effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or rip kinnase signaling pathway显示文摘Boyer L Magoc L Dejardin S 2011Cell Press2011,8,15:1
11Preclinical activity of ABT-869, a multi-targeted receptor tyrosine kinase inhibitor显示文摘Albert DH Tapang P Magoc TJ 2006Mol Cancer Ther2006,5,4:1
12Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor显示文摘ALBERT D H TAPANG P MAGOC T J 2006Mol Cancer Ther2006,5,99:1
13Preclinical activity of ABT-869, a mnititargeted receptor tyrosine kinase inhibitor显示文摘ALBERT D H TAPANG P MAGOC T J 2006Mol Cancer Ther2006,5,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费